NCT03191435 is a NA clinical trial of Inspiratory muscle training. in Diabetes Mellitus, Type 2, sponsored by Hospital de Clinicas de Porto Alegre.

Who is sponsoring NCT03191435?

NCT03191435 is sponsored by Hospital de Clinicas de Porto Alegre.

What drugs are being tested in NCT03191435?

Interventions in NCT03191435: Inspiratory muscle training., Placebo inspiratory muscle.

What condition does NCT03191435 study?

NCT03191435 studies Diabetes Mellitus, Type 2.

Is NCT03191435 still recruiting?

NCT03191435 is currently status unknown. Last updated 14 August 2017.

Last reviewed 2017-08-14 · How we verify

NCT03191435

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Inspiratory Muscle Training on Glycemic Control in Individuals With Type 2 Diabetes

Status unknown NA Last updated 14 August 2017

What this trial tests

NA trial testing Inspiratory muscle training. in Diabetes Mellitus, Type 2 in 30 participants. Status unknown.

Timeline

11 July 2017

Primary endpoint
31 December 2018

31 January 2019

Quick facts

Lead sponsor	Hospital de Clinicas de Porto Alegre
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	30
Start date	11 July 2017
Primary completion	31 December 2018
Estimated completion	31 January 2019
Sites	1 location across Brazil

Drugs / interventions tested

Inspiratory muscle training.
Placebo inspiratory muscle

Conditions studied

Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →

Sponsor

Hospital de Clinicas de Porto Alegre

Who can join

30 and older, any sex, with Diabetes Mellitus, Type 2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In diabetic individuals, changes in ventilatory muscle strength and lung function have been demonstrated over the years. The onset and progression of chronic complications in diabetes should be avoided by reaching glycated hemoglobin (HbA1c) levels below 7%. The control of glycemia through the measurement of HbA1c is fundamental to avoid complications. The inspiratory muscle training has been used in several clinical situations, and may be an alternative for individuals with type 2 diabetes mellitus who have difficulties performing conventional exercises. The long-term effect of inspiratory muscle training on glycemic control has not been tested yet. The aim of this study is to evaluate the effects of inspiratory muscle training on glycemic control in individuals with type 2 diabetes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Inspiratory Muscle Training on Glucose Control in Diabetes: A Randomized Clinical Trial.
Pinto MB, Bock PM, Schein ASO, Portes J, et al · · 2021 · cited 6× · PMID 33248438 · DOI 10.1123/ijsnem.2020-0175

Verify or expand the search:

Other trials of Inspiratory muscle training.

Trials testing the same drug.

NCT05517915 — Inspiratory Muscle Training, Autonomic Dysfunction and Blood Pressure · NA · completed

Other recruiting trials for Diabetes Mellitus, Type 2

Currently open trials in the same condition.

NCT07415954 — A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 · Phase 2 · recruiting
NCT07532863 — A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Part · recruiting
NCT07336329 — Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use · NA · recruiting
NCT07242469 — A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) · Phase 1 · recruiting
NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting

Other Hospital de Clinicas de Porto Alegre trials

Trials by the same sponsor.

NCT07469722 — POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure · Phase 2, PHASE3 · not yet recruiting
NCT07264179 — Tracheal Cuff Pressure and Postoperative Complications: A Prospective Observational Study. · not yet recruiting
NCT07052058 — Triple-Blind Randomized Clinical Trial of Tocilizumab vs Placebo: Potential Use of an IL-6 Antagonist as an Adjuvant to · Phase 2 · not yet recruiting
NCT06953128 — General Versus Regional Anesthesia in Peripheral Arterial Surgery · NA · not yet recruiting
NCT06934707 — Meal Frequency and Glycemic Control in Individuals With Type 1 Diabetes · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03191435 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital de Clinicas de Porto Alegre
Last refreshed: 14 August 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03191435.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing